Accessibility Menu
 

Dechra Enjoys Continued Underlying Growth

The pharmaceutical company reports solid first-half results.

By Jon Wallis Updated Apr 7, 2017 at 1:21PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.